• SpringFestival,14th February,24th February

Holiday arrangements for Chinese SpringFestival. 14th February to 24th February(11days), 9th February will be adjusted towork.

Read more

  • 2014,Shanghai,CPhI & P-MEC China,Exhibition,cphi

Our company successfully exhibitors 2014 Shanghai CPhI & P-MEC China.

Read more

  • Wechat,Gold Sponsor,service,suppliers

ChemCD Blockbuster launch:Concern ChemCD Wechat, to get a three-month Gold Sponsor qualification.

Read more

  • CPhI China 2014,ChemCD,booth number is E3A05

We will take our new website chemcd and software products debut, welcome you visit exchanges and cooperation!

Read more

  • May Day,one-stop service,Gold Sponsor,chemical business

We are planning a promotion for welcomingMay Day, and provide the one-stop service, which can help you to make chemicalbusiness easily. An event named "Gold Sponsor Special Promotion" isbeing

Read more


Recent News

Merck Announces FDA Acceptance of Biologics License Application for Bezlotoxumab, an Investigational Antitoxin for Prevention of Clostridium Difficile Infection Recurrence

Merck announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for bezlotoxumab, an investigational antitoxin for prevention of Clostridium difficile (C. difficile) infection recurrence.

Sanofi and Regeneron Announce Sarilumab Biologics License Application Accepted for Review by US FDA

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for sarilumab.

First data backs efficacy of BMS' novel HIV drug

A Bristol-Myers Squibb (BMS) drug that causes immature HIV particles to be released from cells early, interrupting their lifecycle, has cleared a proof-of-concept study.

EU Rules Could Restrict Genetic Testing

Genetic testing describes the application of laboratory methods to look at a person’s genes (the inherited DNA instructions). Genetic tests can be used to diagnose a genetic condition; screen for a risk of developing a particular health problems; for the selection of treatments; or to assess responses to treatments.

CHMP adopts positive opinion of Edurant in adolescents with HIV-1

The CHMP has adopted a positive opinion recommending a change to the terms of the marketing authorisation for Janssen’s Edurant (rilpivirine) in the EU to extend the indication to adolescent patients aged 12 to <18 years with human immunodeficiency virus-1 (HIV-1) infection

FDA finds mystery 'deficiencies' with Neos' long-acting Ritalin on the eve of approval

Neos Therapeutics got an ominous note from the FDA just weeks ahead of the expected approval date for its long-acting ADHD treatment, clouding the future of the company's lead asset.

Pfizer's once-failed cancer drug wins the FDA's 'breakthrough' tag

Pfizer has found new hope for a former pipeline standout, picking up the FDA's coveted breakthrough therapy designation for a Phase III reclamation project in oncology.